IL HB2350

Group health insurance policies amended, delivered, issued, or renewed after January 1, 2024 must cover annual cervical Pap smear tests for all insureds without deductibles, coinsurance, copayments, or other cost-sharing.

Annual prostate cancer screenings must be covered without cost-sharing for asymptomatic individuals age 50 and over, African-American individuals age 40 and over, and individuals age 40 and over with a family history or genetic predisposition to prostate cancer, upon physician recommendation.

Coverage must include surveillance tests for ovarian cancer (CA-125 testing, transvaginal ultrasound, and pelvic examination) for insureds at risk, including those with family history of ovarian or breast cancer or BRCA1/BRCA2 mutations.

Exemptions apply to specified disease policies, limited benefit coverage, and high-deductible health plans that would lose health savings account eligibility under the Internal Revenue Code.

Prostate cancer screening includes digital rectal exams, prostate-specific antigen tests, laboratory work, and medically necessary follow-up testing such as urinary analysis, serum biomarkers, and medical imaging.